Steward Partners Investment Advisory LLC Has $9.22 Million Position in Axon Enterprise, Inc $AXON

Steward Partners Investment Advisory LLC boosted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 12.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,533 shares of the biotechnology company’s stock after acquiring an additional 1,934 shares during the quarter. Steward Partners Investment Advisory LLC’s holdings in Axon Enterprise were worth $9,221,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. Kentucky Retirement Systems Insurance Trust Fund bought a new stake in shares of Axon Enterprise during the first quarter worth $1,110,000. Quotient Wealth Partners LLC bought a new stake in shares of Axon Enterprise during the first quarter worth $438,000. CX Institutional bought a new stake in shares of Axon Enterprise during the first quarter worth $115,000. GAMMA Investing LLC grew its holdings in shares of Axon Enterprise by 11.8% during the first quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company’s stock worth $765,000 after purchasing an additional 154 shares during the last quarter. Finally, DAVENPORT & Co LLC grew its holdings in shares of Axon Enterprise by 5.1% during the first quarter. DAVENPORT & Co LLC now owns 940 shares of the biotechnology company’s stock worth $494,000 after purchasing an additional 46 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $831.29, for a total transaction of $8,312,900.00. Following the sale, the chief executive officer owned 3,053,982 shares of the company’s stock, valued at $2,538,744,696.78. This trade represents a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Jennifer H. Mak sold 75 shares of the firm’s stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $771.81, for a total value of $57,885.75. Following the sale, the chief accounting officer directly owned 15,240 shares in the company, valued at approximately $11,762,384.40. This represents a 0.49% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 53,695 shares of company stock valued at $40,964,638 over the last 90 days. Insiders own 5.70% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently commented on AXON. JMP Securities increased their target price on Axon Enterprise from $725.00 to $825.00 and gave the stock a “market outperform” rating in a report on Tuesday, July 22nd. Craig Hallum upgraded Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price target on the stock in a report on Tuesday, August 5th. Bank of America raised their price target on Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. UBS Group reiterated a “neutral” rating and issued a $840.00 price target (up previously from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Finally, Morgan Stanley set a $885.00 price target on Axon Enterprise and gave the company an “overweight” rating in a report on Friday, July 11th. Two equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $837.69.

Axon Enterprise Price Performance

Shares of AXON opened at $754.24 on Monday. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 1 year low of $346.71 and a 1 year high of $885.91. The stock has a market cap of $59.21 billion, a P/E ratio of 186.23, a price-to-earnings-growth ratio of 27.68 and a beta of 1.36. The stock’s 50-day moving average price is $773.85 and its two-hundred day moving average price is $670.41.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%. The firm had revenue of $668.54 million for the quarter, compared to analysts’ expectations of $641.77 million. During the same quarter last year, the business earned $1.20 earnings per share. The company’s revenue was up 32.6% compared to the same quarter last year. On average, equities analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.